IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions

OBJECTIVE: To analyze cytokine gene expression in keratinocytes from patients with systemic lupus erythematosus (SLE). INTRODUCTION: Keratinocytes represent 95% of epidermal cells and can secrete several cytokines. METHODS: Keratinocytes were obtained by laser microdissection from 21 patients with SLE (10 discoid and 11 acute lesions) at involved and uninvolved sites. All patients were receiving a low/moderate prednisone dose and 18 were receiving chloroquine diphosphate. IL-2, IL-5, TNF-α and IFN-γ gene expression was evaluated by real-time PCR and expressed as the ratio (R) to a pool of skin samples from 12 healthy volunteers. RESULTS: Heterogeneity in cytokine gene expression was found among patients with SLE. Eighteen of 38 valid SLE samples (47%) presented overexpression (R>1) of at least one cytokine. Lesional skin samples tended to show higher cytokine expression than samples from uninvolved skin (p = 0.06). IL-5 and IFN-γ were the most commonly overexpressed cytokines. Samples with cytokine overexpression corresponded to more extensive and severe lesions. Prednisone dose did not differ between samples without cytokine overexpression (15.71±3.45 mg/day) and those with overexpressed cytokines (12.68±5.41 mg/day) (p = 0.216). Samples from all patients not receiving diphosphate chloroquine had at least one overexpressed cytokine. CONCLUSIONS: The heterogeneous keratinocyte cytokine gene expression reflects the complex immunological and inflammatory background in SLE. Patients with severe/extensive skin lesions showed a higher frequency of cytokine gene overexpression. Increased IFN-γ and IL-5 expression suggests that Th1 and Th2 cells are involved in SLE skin inflammation. The possibility that prednisone and antimalarial drugs may have contributed to low cytokine gene expression in some samples cannot be ruled out.

[1]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[2]  J. Toro,et al.  Detection of type 1 cytokines in discoid lupus erythematosus. , 2000, Archives of dermatology.

[3]  M. Meurer,et al.  Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus , 2000, International journal of dermatology.

[4]  F. Emmrich,et al.  Effects of anti-CD4 antibodies on the release of IL-6 and TNF-α in whole blood samples from patients with systemic lupus erythematosus , 1999, Lupus.

[5]  L. Corral,et al.  Immunomodulation by thalidomide and thalidomide analogues , 1999, Annals of the rheumatic diseases.

[6]  Robert F. Bonner,et al.  Laser Capture Microdissection: Molecular Analysis of Tissue , 1997, Science.

[7]  G. Saed,et al.  T-cell cytokine network in cutaneous lupus erythematosus. , 1997, Journal of the American Academy of Dermatology.

[8]  J. Bernhagen,et al.  MIF as a glucocorticoid-induced modulator of cytokine production , 1995, Nature.

[9]  J. Schröder,et al.  Cytokine networks in the skin. , 1995, The Journal of investigative dermatology.

[10]  D. Schadendorf,et al.  Interleukin‐6 expression in the skin of patients with lupus erythematosus , 1995, Experimental dermatology.

[11]  G. Saed,et al.  Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile. , 1994, The Journal of investigative dermatology.

[12]  M. Yamamura,et al.  The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. , 1993, The Journal of investigative dermatology.

[13]  P. Elias,et al.  Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. , 1992, The Journal of clinical investigation.

[14]  K. Weinberg,et al.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.

[15]  T. Luger,et al.  Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light , 1990, The Journal of experimental medicine.

[16]  T. Luger,et al.  Cytokine modulation of keratinocyte cytokines. , 1990, The Journal of investigative dermatology.

[17]  A. Waage,et al.  Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. , 1988, Immunology.

[18]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[19]  J. A. Robinson Clinics , 1883, The Dental register.

[20]  R. Lahita Chapter 30 – The Clinical Presentation of Systemic Lupus Erythematosus , 2011 .

[21]  L. Aarden,et al.  Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. , 1996, Scandinavian journal of rheumatology.

[22]  I. Chaudry,et al.  Chloroquine inhibits macrophage tumour necrosis factor-alpha mRNA transcription. , 1993, Immunology.